Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)

Leukemia. 1999 Mar;13(3):490-1. doi: 10.1038/sj.leu.2401332.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Clarithromycin / administration & dosage
  • Clarithromycin / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Clarithromycin